Through its MagSense platform, Imagion Biosystems (ASX:IBX) aims to revolutionise cancer diagnosis by introducing molecular imaging to magnetic resonance imaging, better known as MRI. The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback